Raymond James & Associates’s Select Medical SEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $9.11M | Sell |
484,761
-9,471
| -2% | -$178K | 0.01% | 1279 |
|
|
2024
Q2 | $9.34M | Sell |
494,232
-14,459
| -3% | -$273K | 0.01% | 1206 |
|
|
2024
Q1 | $8.26M | Buy |
508,691
+82,201
| +19% | +$1.34M | 0.01% | 1266 |
|
|
2023
Q4 | $5.4M | Sell |
426,490
-58,013
| -12% | -$735K | ﹤0.01% | 1483 |
|
|
2023
Q3 | $6.6M | Sell |
484,503
-4,727
| -1% | -$64.4K | 0.01% | 1282 |
|
|
2023
Q2 | $8.4M | Buy |
489,230
+647
| +0.1% | +$11.1K | 0.01% | 1157 |
|
|
2023
Q1 | $6.8M | Buy |
488,583
+20,776
| +4% | +$289K | 0.01% | 1259 |
|
|
2022
Q4 | $6.26M | Buy |
467,807
+8,325
| +2% | +$111K | 0.01% | 1267 |
|
|
2022
Q3 | $5.47M | Buy |
459,482
+29,352
| +7% | +$349K | 0.01% | 1319 |
|
|
2022
Q2 | $5.47M | Buy |
430,130
+20,128
| +5% | +$256K | 0.01% | 1343 |
|
|
2022
Q1 | $5.3M | Buy |
410,002
+98,884
| +32% | +$1.28M | ﹤0.01% | 1467 |
|
|
2021
Q4 | $4.93M | Sell |
311,118
-6,919
| -2% | -$110K | ﹤0.01% | 1558 |
|
|
2021
Q3 | $6.2M | Buy |
318,037
+245,848
| +341% | +$4.79M | 0.01% | 1356 |
|
|
2021
Q2 | $1.64M | Buy |
72,189
+10,347
| +17% | +$236K | ﹤0.01% | 2240 |
|
|
2021
Q1 | $1.14M | Buy |
61,842
+8,456
| +16% | +$155K | ﹤0.01% | 2414 |
|
|
2020
Q4 | $796K | Buy |
53,386
+22,946
| +75% | +$342K | ﹤0.01% | 2479 |
|
|
2020
Q3 | $341K | Buy |
+30,440
| New | +$341K | ﹤0.01% | 2858 |
|
|
2020
Q2 | – | Sell |
-23,584
| Closed | -$191K | – | 3511 |
|
|
2020
Q1 | $191K | Sell |
23,584
-58
| -0.2% | -$470 | ﹤0.01% | 3043 |
|
|
2019
Q4 | $297K | Buy |
+23,642
| New | +$297K | ﹤0.01% | 3077 |
|